BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 22551358)

  • 1. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
    Berk DR; Ball Arefiev KL; Gladstone HB
    Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
    Hendrix JD; Parlette HL
    Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
    Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
    Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
    Aoyagi S; Nouri K
    Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial basal cell carcinomas of the head and neck.
    Mina MA; Picariello A; Fewkes JL
    Dermatol Surg; 2013 Jul; 39(7):1003-8. PubMed ID: 23465089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):624-30. PubMed ID: 15051192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane.
    Orengo IF; Salasche SJ; Fewkes J; Khan J; Thornby J; Rubin F
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):395-7. PubMed ID: 9308552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epiluminescence microscopy (dermoscopy) versus visual inspection during Mohs microscopic surgery of infiltrative basal cell carcinoma.
    Gurgen J; Gatti M
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1066-9. PubMed ID: 22676346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007).
    Lim P; Paver R; PeƱas PF
    J Am Acad Dermatol; 2010 Nov; 63(5):832-5. PubMed ID: 20950738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triage in Mohs micrographic surgery.
    Miladi A; Bingham J
    J Drugs Dermatol; 2011 Mar; 10(3):257-9. PubMed ID: 21369641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
    Florell SR; Layfield LJ; Gerwels JW
    J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
    Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
    Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
    Lim GF; Perez OA; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.